Study Evaluating TRU-015 in B-Cell Non-Hodgkin's Lymphoma

NCT00521638 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, B-Cell

Interventions

BIOLOGICAL: TRU-015

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer

Collaborators

[object Object]